The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Abstract
Inflammasomes are Nod-like receptor(NLR)- and caspase-1-containing cytoplasmic multiprotein complexes, which upon their assembly, process and activate the proinflammatory cytokines interleukin (IL)-1beta and IL-18. The inflammasomes harboring the NLR members NALP1, NALP3 and IPAF have been best characterized. While the IPAF inflammasome is activated by bacterial flagellin, activation of the NALP3 inflammasome is triggered not only by several microbial components, but also by a plethora of danger-associated host molecules such as uric acid. How NALP3 senses these chemically unrelated activators is not known. Here, we provide evidence that activation of NALP3, but not of the IPAF inflammasome, is blocked by inhibiting K(+) efflux from cells. Low intracellular K(+) is also a requirement for NALP1 inflammasome activation by lethal toxin of Bacillus anthracis. In vitro, NALP inflammasome assembly and caspase-1 recruitment occurs spontaneously at K(+) concentrations below 90 mM, but is prevented at higher concentrations. Thus, low intracellular K(+) may be the least common trigger of NALP-inflammasome activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In favour of the latter assumption is the recent finding that potassium (K + ) efflux, lowering intracellular K + levels, is a requirement for Nalp3 inflammasome activation triggered by all known activators including MSU (13)(14)(15).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [13]
In the citing paper
“Recent data also suggest a role for ROS in activating caspase-1 upon ATP treatment (18) and in Nalp3 inflammasome activation by MSU and R837 (13).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [13]
In the citing paper
“Decreased K+ levels in the cytosolic microenvironment may lead to NLRP3 inflammasome assembly and activation through NIMA-related serine/threonine kinase 7 (Nek7) binding, which culminates in the secretion of inflammatory cytokines, such as IL-1β and IL-18 [151,152]”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [152]
In the citing paper
“Consistently, inhibition of K+ efflux by high extracellular K+ concentrations prevents NLRP3-dependent caspase 1 activation in response to ATP, asbestos, silica and MSU crystals58,66.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [66]
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationThe innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,605
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,864
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationBacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
Kanneganti, T., Özören, N., Body–Malapel, M., Amer, A. O., Park, J., Franchi, L., Whitfield, J. R., Barchet, W., Colonna, M., Vandenabeele, P., et al. (2006) · Nature · doi:10.1038/nature04517 · Cited by 1,149
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Núñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 1,019
Cited by
Sorted by citations
Items 501–600 of 1,003
The NLRP 3 inflammasome: role in airway inflammation
Im, H., & Ammit, A. J. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12206 · Cited by 80
Nickel Induces Interleukin-1β Secretion via the NLRP3–ASC–Caspase-1 Pathway
Li, X., & Zhong, F. (2013) · Inflammation · doi:10.1007/s10753-013-9759-z · Cited by 78
Activating immunity: lessons from the TLRs and NLRs
Monie, T. P., Bryant, C. E., & Gay, N. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.011 · Cited by 80
Nomura, J., So, A. K.-L., Tamura, M., & Busso, N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402512 · Cited by 79
THE ROLE OF INNATE IMMUNITY IN SEPTIC ACUTE KIDNEY INJURIES
Gonçalves, G. M., Zamboni, D. S., & Câmara, N. O. S. (2010) · Shock · doi:10.1097/shk.0b013e3181e7e69e · Cited by 78
Microbial metabolites in the pathogenesis of periodontal diseases: a narrative review
Basic, A., & Dahlén, G. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1210200 · Cited by 87
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hoffman, H. M., & Brydges, S. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135491 · Cited by 79
Pascual, V., Allantaz, F., Patel, P., Palucka, K., Chaussabel, D., & Banchereau, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00643.x · Cited by 78
The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
Yang, C., Shin, D., & Jo, E. (2012) · International Neurourology Journal · doi:10.5213/inj.2012.16.1.2 · Cited by 81
Lacroix‐Lamandé, S., d’Andon, M. F., Michel, E., Ratet, G., Philpott, D. J., Girardin, S. E., Boneca, I. G., Vandewalle, A., & Werts, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101987 · Cited by 78
Santos, D. F., Campos, T. M., Saldanha, M. G., Oliveira, S. C., Nascimento, M. T., Zamboni, D. S., Machado, P. R. L., Arruda, S. M., Scott, P., Carvalho, E. M., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.11.029 · Cited by 77
Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170407123522 · Cited by 76
Yasukawa, S., Miyazaki, Y., Yoshii, C., Nakaya, M., Ozaki, N., Toda, S., Kuroda, E., Ishibashi, K.-I., Yasuda, T., Natsuaki, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4755 · Cited by 77
Inflammasomes and Their Activation
Khare, S., Luc, N., Dorfleutner, A., & Stehlik, C. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i5.50 · Cited by 77
MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2
Bandyopadhyay, S., Lane, T., Rajanbabu, V., Parthasarathy, P. T., Cho, Y., Galam, L., Lockey, R. F., & Kolliputi, N. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.056 · Cited by 77
Neonatal autoimmune diseases: A critical review
Chang, C. C.-C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.018 · Cited by 77
Beneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 79
Shi, W., Xu, G., Zhan, X., Gao, Y., Wang, Z., Fu, S., Qin, N., Hou, X., Ai, Y., Wang, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2460-x · Cited by 76
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
Mezzaroma, E., Abbate, A., & Toldo, S. A. (2021) · Molecules · doi:10.3390/molecules26040976 · Cited by 79
The Role of the Inflammasome in Heart Failure
Wu, J., Dong, E., Zhang, Y., & Xiao, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709703 · Cited by 78
A review on gout: Looking back and looking ahead
Tao, H., Mo, Y., Liu, W., & Wang, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109977 · Cited by 77
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
Bulté, D., Rigamonti, C., Romano, A., & Mortellaro, A. (2023) · Cells · doi:10.3390/cells12131766 · Cited by 83
Inflammasomes and rheumatic diseases: evolving concepts
Sidiropoulos, P. I., Goulielmos, G. N., Voloudakis, G., Petraki, E., & Boumpas, D. T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.078014 · Cited by 76
Optogenetic activation of spinal microglia triggers chronic pain in mice
Yi, M., Liu, Y., Umpierre, A. D., Chen, T., Ying, Y., Zheng, J., Dheer, A., Bosco, D. B., Dong, H., & Wu, L. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001154 · Cited by 76
Sharma, B., Satija, G., Madan, A., Garg, M., Alam, M. M., Shaquiquzzaman, M., Khanna, S., Tiwari, P., Parvez, S., Iqubal, A., et al. (2022) · Inflammation · doi:10.1007/s10753-022-01730-0 · Cited by 77
Targeting NLRP3 inflammasome for neurodegenerative disorders
Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 81
The rhapsody of NLRPs: master players of inflammation … and a lot more
Zambetti, L. P., Laudisi, F., Licandro, G., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8272-z · Cited by 75
Enniatin B-induced cell death and inflammatory responses in RAW 267.4 murine macrophages
Gammelsrud, A. Ø., Solhaug, A., Dendelé, B., Sandberg, W. J., Ivanova, L., Bølling, A. K., Lagadic‐Gossmann, D., Refsnes, M., Becher, R., Eriksen, G. S., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.014 · Cited by 79
Molecular determinants of sterile inflammation
Kono, H., Onda, A., & Yanagida, T. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.004 · Cited by 77
Current status of inflammasome blockers as anti-inflammatory drugs
López‐Castejón, G., & Pelegrı́n, P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.690032 · Cited by 77
Control of innate and adaptive immunity by the inflammasome
Çıracı, C., Janczy, J. R., Sutterwala, F. S., & Cassel, S. L. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.07.007 · Cited by 75
Piippo, N., Korhonen, E., Hytti, M., Kinnunen, K., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492886 · Cited by 74
Interactions of nanomaterials with ion channels and related mechanisms
Yin, S., Liu, J., Kang, Y., Lin, Y., Li, D., & Shao, L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14792 · Cited by 76
Cellular Models and Assays to Study NLRP3 Inflammasome Biology
Zito, G., Buscetta, M., Cimino, M., Dino, P., Bucchieri, F., & Cipollina, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124294 · Cited by 80
The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
Ishrat, T., Ismael, S., Ahmed, H. A., Adris, T., Parveen, K., & Thakor, P. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.286951 · Cited by 74
More Than a Pore: The Cellular Response to Cholesterol-Dependent Cytolysins
Cassidy, S. K. B., & O’Riordan, M. X. (2013) · Toxins · doi:10.3390/toxins5040618 · Cited by 74
Integrin-Mediated First Signal for Inflammasome Activation in Intestinal Epithelial Cells
Thinwa, J. W., Segovia, J. A., Bose, S., & Dube, P. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400145 · Cited by 76
Marón, F. J. M., Ferder, L., Saraví, F. D., & Manucha, W. A. (2018) · Stress · doi:10.1080/10253890.2018.1542683 · Cited by 80
NLRP7: From inflammasome regulation to human disease
Carrière, J., Dorfleutner, A., & Stehlik, C. (2021) · Immunology · doi:10.1111/imm.13372 · Cited by 78
Ma, D.-C., Zhang, N., Zhang, Y., & Chen, D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113399 · Cited by 72
Recent advances in ZBP1-derived PANoptosis against viral infections
Oh, S., & Lee, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148727 · Cited by 76
Caspases as therapeutic targets
Howley, B. A., & Fearnhead, H. O. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00292.x · Cited by 73
Wang, L., Qu, P., Zhao, J., & Chang, Y. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44871 · Cited by 71
Li, Z., Huang, Z., Zhang, H., Lu, J., Tian, Y., Piao, S., Lin, Z., & Bai, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00746-z · Cited by 71
Cole, J., Aberdein, J., Jubrail, J., & Dockrell, D. H. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.004 · Cited by 71
Jun, H., Lee, S., Lee, H., & Choi, B. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.002 · Cited by 71
Gordon, E. M., Yao, X., Xu, H., Karkowsky, W., Kaler, M. M., Kalchiem‐Dekel, O., Barochia, A. V., Gao, M., Keeran, K. J., Jeffries, K. R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.02.027 · Cited by 70
Schweneker, K., Gorka, O., Schweneker, M., Poeck, H., Tschopp, J., Peschel, C., Ruland, J., & Groß, O. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.029 · Cited by 70
Self-citationThe strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Jiang, H., Gong, T., & Zhou, R. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.003 · Cited by 71
Human NLRP1: From the shadows to center stage
Bauernfried, S., & Hornung, V. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211405 · Cited by 72
Hoffman, H. M., Scott, P., Mueller, J. L., Misaghi, A., Stevens, S. G., Yancopoulos, G. D., Murphy, A. J., Valenzuela, D. M., & Liu‐Bryan, R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27456 · Cited by 70
Activation of NLRP3 inflammasome in human neutrophils by Helicobacter pylori infection
Figueroa, G., Torres, J., Sánchez-Zauco, N. A., Contreras‐Ramos, A., Álvarez‐Arellano, L., & Maldonado‐Bernal, C. (2015) · Innate Immunity · doi:10.1177/1753425915619475 · Cited by 70
Chen, M., Xing, Y., Lu, A., Fang, W. Y., Sun, B., Chen, C., Liao, W., & Meng, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500865 · Cited by 67
The Role of P2X7 Receptor in Alzheimer’s Disease
Francistiová, L., Bianchi, C., Lauro, C. D., Sebastián‐Serrano, Á., de Diego-García, L., Kobolák, J., Dinnyés, A., & Díaz-Hernández, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00094 · Cited by 73
Activation and Evasion of Antiviral Innate Immunity by Hepatitis C Virus
Horner, S. M. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.032 · Cited by 73
Pyroptotic and non‐pyroptotic effector functions of caspase‐11
Khweek, A. A., & Amer, A. O. (2020) · Immunological Reviews · doi:10.1111/imr.12910 · Cited by 71
NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?
Zhou, F., Li, C., & Zhang, S. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001214 · Cited by 71
Evaluation of Nod-Like Receptor (NLR) Effector Domain Interactions
Wagner, R. N., Proell, M., Kufer, T. A., & Schwarzenbacher, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004931 · Cited by 69
NOD-Like Receptors in Lung Diseases
Chaput, C., Sander, L. E., Suttorp, N., & Opitz, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00393 · Cited by 75
Transfusion-Related Acute Lung Injury: The Work of DAMPs*
Land, W. G. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000345688 · Cited by 69
Francisella tularensis Reveals a Disparity between Human and Mouse NLRP3 Inflammasome Activation
Atianand, M., Duffy, E. B., Shah, A., Kar, S., Malik, M., & Harton, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244079 · Cited by 73
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
Zhang, L., Ai, C., Bai, M., Niu, J., & Zhang, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810632 · Cited by 73
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Xia, J., Jiang, S., Dong, S., Liao, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076126 · Cited by 74
Pannexin‐1‐dependent caspase‐1 activation and secretion of IL‐1β is regulated by zinc
Brough, D., Pelegrı́n, P., & Rothwell, N. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200838843 · Cited by 68
Adaptive network nanomedicine an integrated model for homeopathic medicine
Bell, I. R. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s400 · Cited by 68
Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells
Piippo, N., Korkmaz, A., Hytti, M., Kinnunen, K., Salminen, A., Atalay, M., Kaarniranta, K., & Kauppinen, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.015 · Cited by 69
NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers
Claes, A.-K., Zhou, J. Y., & Philpott, D. J. (2015) · Physiology · doi:10.1152/physiol.00025.2014 · Cited by 75
Adam, C., Wohlfarth, J., Haußmann, M., Sennefelder, H., Rodin, A., Maler, M. D., Martin, S. F., Goebeler, M., & Schmidt, M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.003 · Cited by 68
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Li, X., Zhang, Z., Wang, Z., Gutiérrez-Castrellón, P., & Shi, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01043-6 · Cited by 67
Nod-Like Receptors: Cytosolic Watchdogs for Immunity against Pathogens
Sirard, J., Vignal, C., Dessein, R., & Chamaillard, M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030152 · Cited by 72
Averette, K. M., Pratt, M. R., Yang, Y., Bassilian, S., Whitelegge, J. P., Loo, J. A., Muir, T. W., & Bradley, K. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007913 · Cited by 66
Emerging Significance of NLRs in Inflammatory Bowel Disease
Davis, B. K., Philipson, C. W., Hontecillas, R., Eden, K. B., Bassaganya-Riera, J., & Allen, I. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000151 · Cited by 69
KCNN4 links PIEZO-dependent mechanotransduction to NLRP3 inflammasome activation
Ran, L., Ye, T., Erbs, E., Ehl, S. R., Spassky, N., Sumara, I., Zhang, Z., & Ricci, R. (2023) · Science Immunology · doi:10.1126/sciimmunol.adf4699 · Cited by 68
Benkő, S., Magyarics, Z., Szabó, A., & Rajnavölgyi, É. (2008) · Biological Chemistry · doi:10.1515/bc.2008.054 · Cited by 66
NLRP3 and IL ‐1 β in macrophages as critical regulators of metabolic diseases
McGettrick, A. F., & O'Neill, L. A. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12169 · Cited by 68
Role of Genetic Alterations in the NLRP3 and CARD8 Genes in Health and Disease
Paramel, G. V., Sirsjö, A., & Fransén, K. (2015) · Mediators of Inflammation · doi:10.1155/2015/846782 · Cited by 66
McCoy, A. J., Koizumi, Y., Higa, N., & Suzuki, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002165 · Cited by 66
Chronic glucocorticoid exposure activates BK-NLRP1 signal involving in hippocampal neuron damage
Zhang, B., Zhang, Y., Wu, W., Xu, T., Yin, Y., Zhang, J., Huang, D., & Li, W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0911-9 · Cited by 66
Targeting pattern-recognition receptors to discover new small molecule immune modulators
Zhu, G., Xu, Y., Cen, X., Nandakumar, K. S., Liu, S., & Cheng, K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.026 · Cited by 68
NLRP 3 inflammasome: A likely target for the treatment of allergic diseases
Xiao, Y., Xu, W., & Su, W. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13190 · Cited by 66
Metabolic regulation of inflammasomes in inflammation
Yang, Q., Liu, R., Yu, Q., Bi, Y., & Liu, G. (2019) · Immunology · doi:10.1111/imm.13056 · Cited by 68
Correction: Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
Shio, M. T., Eisenbarth, S. C., Savaria, M., Vinet, A. F., Bellemare, M.-J., Harder, K. W., Sutterwala, F. S., Bohle, D. S., Descoteaux, A., Flavell, R. A., et al. (2009) · PLoS Pathogens · doi:10.1371/annotation/abca067d-b82b-4de6-93c5-0fcc38e3df05 · Cited by 66
Lee, H., Kang, J., Lee, S. J., & Jo, E. (2012) · Glia · doi:10.1002/glia.22448 · Cited by 65
Nucleic acid-associated autoantigens: Pathogenic involvement and therapeutic potential
Hoffmann, M. H., Trembleau, S., Muller, S., & Steiner, G. E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.013 · Cited by 66
Ruwona, T. B., Xu, H., Li, X., Taylor, A. N., Shi, Y.-C., & Cui, Z. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.081 · Cited by 64
Inner sensors of endotoxin – implications for sepsis research and therapy
Skirecki, T., & Cavaillon, J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz004 · Cited by 64
Ram, C., Jha, A. K., Ghosh, A., Gairola, S., Syed, A. M., Murty, U. S., Naidu, V. G. M., & Sahu, B. D. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173503 · Cited by 64
Elrashdy, F., Redwan, E. M. M. M., & Uversky, V. N. (2020) · Biomolecules · doi:10.3390/biom10091312 · Cited by 64
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
Choudhury, S. M., Ma, X., Abdullah, S. W., & Zheng, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s295706 · Cited by 66
Trendelenburg, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600609 · Cited by 64
Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro‐inflammatory phenotype
Xiong, J., & Kielian, T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12385 · Cited by 64
Huang, X., Yang, X., Ni, J., Xie, B., Liu, Y., Xuan, D., & Zhang, J. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.140403 · Cited by 63
The Dual Role of Nod-Like Receptors in Mucosal Innate Immunity and Chronic Intestinal Inflammation
Corridoni, D., Arseneau, K. O., Cifone, M. G., & Cominelli, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00317 · Cited by 66
Alvarado, R., To, J., Lund, M. E., Pinar, A. A., Mansell, A. S., Robinson, M. W., O’Brien, B. A., Dalton, J. P., & Donnelly, S. (2016) · The FASEB Journal · doi:10.1096/fj.201500093r · Cited by 61
Pal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2017) · Endocrinology · doi:10.1210/en.2017-00294 · Cited by 63
Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?
Wallert, M., Börmel, L., & Lorkowski, S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000097 · Cited by 68
Actual status of antiinterleukin-1 therapies in rheumatic diseases
Geyer, M., & Müller‐Ladner, U. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283373fa0 · Cited by 62
How Frustration Leads to Inflammation
O'Neill, L. A. J. (2008) · Science · doi:10.1126/science.1158398 · Cited by 62
The role of inflammation and interleukin-1 in acute cerebrovascular disease
Brough, D., & Galea, J. P. (2013) · Journal of Inflammation Research · doi:10.2147/jir.s35629 · Cited by 63
Kurenuma, T., Kawamura, I., Hara, H., Uchiyama, R., Daim, S. J., Dewamitta, S. R., Sakai, S., Tsuchiya, K., Nomura, T., & Mitsuyama, M. (2009) · Infection and Immunity · doi:10.1128/iai.00015-09 · Cited by 62
Metadata
- Authors
- Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J.
- Affiliations
- University of Lausanne (CH)
- Harvard University (US)
- Corresponding author
- Tschopp, J
- Venue
- Cell Death & Differentiation
- Published
- 2007-06-29
- Volume
- 14
- Issue
- 9
- Pages
- 1583-1589
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1978274182
- Cited by
- 1,445
- References
- 38
- Citations by year
- 2026: 36 · 2025: 54 · 2024: 62 · 2023: 71 · 2022: 85 · 2021: 78 · 2020: 102 · 2019: 86 · 2018: 73 · 2017: 104 · 2016: 70 · 2015: 79 · 2014: 90 · 2013: 101 · 2012: 93
- FWCI
- 25.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- NLRP3 inflammasome, potassium efflux, intracellular potassium concentration, caspase-1 activation, inflammasome assembly, NOD-like receptors, damage-associated molecular patterns, uric acid, IL-1β, IL-18
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Calcium-Binding Proteins, Carrier Proteins, Cell Line, Humans, Inflammation, Mice, Inbred BALB C, Mice, Inbred C57BL, Potassium, Macrophages, Peritoneal, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
